导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -8.09% | 3638/4773 |
| 近一周 | -2.86% | 4332/5465 |
| 近一月 | -2.34% | 1604/5421 |
| 近一季 | -9.85% | 3658/5231 |
| 近半年 | -16.46% | 4176/4920 |
| 近一年 | -8.82% | 3344/4394 |
| 近两年 | 43.72% | 1736/2954 |
| 近三年 | 6.78% | 1812/2253 |
| 成立以来 | -37.70% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
1.99% 1108/4961 |
-4.53% 3516/5312 |
- - |
- - |
| 2025 | 17.75% 2356/4813 |
3.18% 1163/3635 |
3.04% 1186/4076 |
12.15% 3096/4524 |
-1.25% 2885/4813 |
| 2024 | 7.01% 1700/3463 |
-5.32% 1871/2808 |
-10.93% 2478/3014 |
18.27% 1030/3129 |
7.30% 453/3463 |
| 2023 | -12.02% 1441/2656 |
3.75% 1134/2280 |
-3.04% 734/2385 |
-6.25% 1462/2515 |
-6.71% 1883/2655 |
| 2022 | -24.60% 1232/2207 |
-13.55% 781/1919 |
-2.22% 1768/2016 |
-9.03% 237/2113 |
-1.95% 1760/2208 |
| 2021 | 22.06% 155/1822 |
7.10% 83/1255 |
-5.13% 1272/1330 |
15.06% 78/1466 |
4.40% 333/1822 |
| 2020 | -1.49% 954/1250 |
-3.90% 328/1028 |
3.88% 925/1067 |
6.49% 833/1164 |
-7.33% 1154/1184 |
| 2019 | 6.35% 741/1092 |
22.96% 566/754 |
-5.93% 489/804 |
-8.87% 831/850 |
0.89% 881/918 |
| 2018 | -43.81% 621/834 |
- - |
- - |
- - |
-9.25% 139/691 |
| 2017 | -6.97% 518/714 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 汇添富中证环境治理指数(LOF)C VS. 长安沪深300非周期A(740101) |